Matinas BioPharma Holdings Inc Sustainability Reports

Matinas Biopharma Holdings Inc. focuses on developing innovative lipid-based prescription therapies for the treatment of infectious diseases and rare disorders.

Sector: Health Care

Country: United States

Exchange: NYSE American

ISIN: US5768101058

3 reports from 2020 to 2024

Company Profile

Matinas BioPharma Holdings Inc

Matinas Biopharma Holdings Inc. focuses on developing innovative lipid-based prescription therapies for the treatment of infectious diseases and rare disorders.

MIC

 

Ticker

 

ISIN

 

Website

www.matinasbiopharma.com

Country

United States

Exchange

NYSE American

Sector

Health Care

Industry

Pharmaceuticals, Biotechnology & Life Sciences

Reports

Available reports